Four of the nation's largest industry superannuation funds have backed a venture capital fund aiming to stem the tide of jobs and revenue generated by Australian medical science breakthroughs heading offshore. Brandon Capital Partners' third Medical Research Commercialisation Fund will announce this week it has raised $200 million from AustralianSuper, HESTA, StatewideSuper and Hostplus.